Arveschoug Anne Kirstine, Bertelsen Henrik, Vammen Birthe
Department of Clinical Physiology, Aalborg Hospital, DK-9100 Aalborg, Denmark.
Clin Nucl Med. 2002 Apr;27(4):249-54. doi: 10.1097/00003072-200204000-00003.
Scintigraphy using Tc-99m sestamibi is sensitive in localizing abnormal parathyroid glands in patients with hyperparathyroid disease (HPT). Various methods have been described to increase the sensitivity of the single-tracer technique, such as SPECT, factor analysis of dynamic structures, and use of a pinhole collimator, but often the gain in sensitivity is accompanied by a loss of specificity.
In this study, the authors compared the sensitivity and specificity of side localization of the diseased gland(s) using the double-phase single-tracer method performed with and without the addition of a pinhole collimator in the early and late phases of imaging. The combined high-resolution parallel-hole and pinhole collimator imaging protocol was further validated by investigation of interobserver and intraobserver variation.
Forty-seven patients with primary HPT and 16 patients with secondary HPT examined from 1996 to 1999 with the Tc-99m sestamibi double-phase technique and who had subsequent surgery formed the basis of the study. Their histologic and follow-up data were also factored into this analysis. Tc-99m sestamibi (750 to 900 MBq; 18.9 to 24.3 mCi) was injected. Ten-minute neck and mediastinum images acquiring 1,000 K counts were obtained with the high-resolution parallel-hole collimator, and a neck image containing 500 K counts was obtained with the pinhole collimator. Two to three hours later, the same parallel-hole and pinhole collimator images were obtained that had the same acquisition time as the early images. Two observers who were nuclear medicine specialists independently viewed all the parallel-hole scintigrams and afterward all parallel-hole and pinhole scintigrams two times.
Thirty-eight (81%) of the patients with primary HPT had a single adenoma. The sensitivity and specificity for the correct side of localization were 54% and 89%, respectively, using the high-resolution parallel-hole collimator, and 88% and 77%, respectively, with the addition of the pinhole collimator in all patients with primary HPT. In patients with secondary HPT, the sensitivity and specificity for localization of the correct side were 58% and 100%, respectively, using the high-resolution parallel-hole collimator, and 85% and 100%, respectively, with the addition of the pinhole collimator. The interobserver agreement was acceptable, with an overall agreement of 84% and a kappa value of 0.67. The intraobserver agreement was even better, with an overall agreement of 88% and 90% and kappa values of 0.76 and 0.79 for the two observers.
Sensitivity is increased considerably when the pinhole collimator is added to the imaging protocol of parathyroid scintigraphy in patients with primary or secondary HPT. A loss of specificity occurred only in patients with primary HPT. The precision of the combined approach is very high.
使用锝-99m 甲氧基异丁基异腈(Tc-99m sestamibi)进行闪烁扫描在定位甲状旁腺功能亢进症(HPT)患者异常甲状旁腺方面具有较高敏感性。已描述了多种提高单示踪剂技术敏感性的方法,如单光子发射计算机断层扫描(SPECT)、动态结构因子分析以及使用针孔准直器,但敏感性的提高往往伴随着特异性的降低。
在本研究中,作者比较了在成像的早期和晚期使用或不使用针孔准直器进行双相单示踪剂方法时,患病腺体侧方定位的敏感性和特异性。通过研究观察者间和观察者内的差异,进一步验证了高分辨率平行孔和针孔准直器联合成像方案。
1996 年至 1999 年期间,47 例原发性 HPT 患者和 16 例继发性 HPT 患者接受了 Tc-99m sestamibi 双相技术检查,并随后接受了手术,这些患者构成了本研究的基础。他们的组织学和随访数据也纳入了该分析。静脉注射 Tc-99m sestamibi(750 至 900 兆贝克勒尔;18.9 至 24.3 毫居里)。使用高分辨率平行孔准直器获取 10 分钟的颈部和纵隔图像,采集 1000K 计数,使用针孔准直器获取包含 500K 计数的颈部图像。两到三小时后,获取与早期图像采集时间相同的相同平行孔和针孔准直器图像。两名核医学专家独立观察所有平行孔闪烁扫描图,之后两次观察所有平行孔和针孔闪烁扫描图。
38 例(81%)原发性 HPT 患者患有单一腺瘤。在所有原发性 HPT 患者中,使用高分辨率平行孔准直器时,正确侧方定位的敏感性和特异性分别为 54%和 89%,添加针孔准直器后分别为 88%和 77%。在继发性 HPT 患者中,使用高分辨率平行孔准直器时,正确侧方定位的敏感性和特异性分别为 58%和 100%,添加针孔准直器后分别为 85%和 100%。观察者间一致性可接受,总体一致性为 84%,kappa 值为 0.67。观察者内一致性更好,两名观察者的总体一致性分别为 88%和 90%,kappa 值分别为 0.76 和 0.79。
在原发性或继发性 HPT 患者的甲状旁腺闪烁扫描成像方案中添加针孔准直器时,敏感性显著提高。仅在原发性 HPT 患者中出现特异性降低。联合方法的精确性非常高。